Researchers of SZATKI participate in the Horizon 2020 AIDPATH project that aims to facilitate the so-called CAR-T therapies tailored to individual patients by using the cutting-edge achievements in artificial intelligence as well as production planning and scheduling techniques. The results are expected to be utilized in hematology, oncology, and handling various contagious and immune diseases. 

With the Institute for Computer Science and Control (SZTAKI), Hungary, as artificial intelligence developer partner, the Hexa-X flagship project received 12MEUR funding from the European Commission for research in beyond 5G/6G radio technology connecting human, physical, and digital worlds.